Caribou Biosciences (CRBU) Leases (2022 - 2025)
Historic Leases for Caribou Biosciences (CRBU) over the last 4 years, with Q3 2025 value amounting to $16.0 million.
- Caribou Biosciences' Leases fell 2190.5% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year decrease of 2190.5%. This contributed to the annual value of $20.0 million for FY2024, which is 979.62% down from last year.
- Per Caribou Biosciences' latest filing, its Leases stood at $16.0 million for Q3 2025, which was down 2190.5% from $16.5 million recorded in Q2 2025.
- Over the past 5 years, Caribou Biosciences' Leases peaked at $25.7 million during Q1 2022, and registered a low of $16.0 million during Q3 2025.
- For the 4-year period, Caribou Biosciences' Leases averaged around $21.8 million, with its median value being $22.2 million (2023).
- In the last 5 years, Caribou Biosciences' Leases tumbled by 789.93% in 2023 and then plummeted by 2211.13% in 2025.
- Over the past 4 years, Caribou Biosciences' Leases (Quarter) stood at $24.2 million in 2022, then decreased by 8.45% to $22.2 million in 2023, then fell by 9.8% to $20.0 million in 2024, then decreased by 20.02% to $16.0 million in 2025.
- Its last three reported values are $16.0 million in Q3 2025, $16.5 million for Q2 2025, and $19.5 million during Q1 2025.